The UK Government will invest £100 million in the Ayrshire Growth Deal, the Scottish Secretary David Mundell has announced today as he visited HALO Kilmarnock and Ayrshire College.
The HALO Scotland, today announces it will be partnering with Barclays at its Kilmarnock urban regeneration site, which will seek to develop entrepreneurship and the employability skills of young people and adults across Scotland.
The Port of Rosyth, Scotland’s best connected port, has welcomed their new Liebherr multimillion pound mobile harbour crane at the port for bulk handling primarily for Cefetra.
Screen Scotland seeks operator for major Film & TV production facility at The Port of Leith, Edinburgh, a private gated 8.6 acre site within the port estate and is owned by Forth Ports Limited.
The Port of Grangemouth’s new multimillion pound crane gets to work this month at Scotland’s largest container terminal.
Loch Duart salmon farm has partnered with award winning environmental organisation Plan Bee Ltd. to protect Scotland’s unique pollinators, the honey and bumble bees.
Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces today that the Committee for Medicinal Products for Human Use (CHMP), the European Medicines Agency’s (EMA) scientific committee, has adopted a Positive Opinion recommending approval of the marketing authorisation of mogamulizumab
Forth Ports Limited, one of the UK’s largest port groups, has for the first time won the Corporate Social Responsibility (CSR) award at last night’s Logistics Awards 2018 in London.
Co-lead investment in Optoscribe from Archangels and Maven set to facilitate increase in manufacturing capacity and engineering resource, to meet customer demand.
Independent salmon farm Loch Duart recognised at Sunday Times HSBC International Track 200 awards ceremony, which featured speakers from boohoo.com and Gymshark
MGB Biopharma’s anti-bacterial agent for treatment of C. difficile infections, helped by Archangels funding round, to enter Phase II clinical trials
Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces today that the U.S. Food and Drug Administration (FDA) has granted approval for Poteligeo®